Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
Multiple sclerosis and family planning.
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity.
Aquaporin water channels in the nervous system.
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
Prolactin in multiple sclerosis.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Therapeutic aspects of cannabis and cannabinoids.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
[Affective and psychotic disorders in multiple sclerosis].
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
Lhermitte's Sign: The Current Status.
General Practitioner Preferences in Managing Care of Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
301
302
303
304
305
306
307
308
309
…
next ›
last »